PL2010538T3 - Sposób otrzymywania estru 2-[4-(4-fluoro-2-metylo-1H-indolo-5-iloksy)-5-metylopirolo[2,1-f][1,2,4]triazyn-6-iloksy]-1-metyloetylowego kwasu [(1R), 2S]-2-aminopropionowego - Google Patents

Sposób otrzymywania estru 2-[4-(4-fluoro-2-metylo-1H-indolo-5-iloksy)-5-metylopirolo[2,1-f][1,2,4]triazyn-6-iloksy]-1-metyloetylowego kwasu [(1R), 2S]-2-aminopropionowego

Info

Publication number
PL2010538T3
PL2010538T3 PL07760872T PL07760872T PL2010538T3 PL 2010538 T3 PL2010538 T3 PL 2010538T3 PL 07760872 T PL07760872 T PL 07760872T PL 07760872 T PL07760872 T PL 07760872T PL 2010538 T3 PL2010538 T3 PL 2010538T3
Authority
PL
Poland
Prior art keywords
yloxy
triazin
indol
fluoro
methyl
Prior art date
Application number
PL07760872T
Other languages
English (en)
Inventor
Gerard A Crispino
Mourad Hamedi
Thomas L Laporte
John E Thornton
Jaan A Pesti
Zhongmin Xu
Paul C Lobben
David K Leahy
Jale Muslehiddinoglu
Chiajen Lai
Lori Ann Spangler
Robert P Discordia
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38357966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2010538(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PL2010538T3 publication Critical patent/PL2010538T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL07760872T 2006-04-21 2007-04-19 Sposób otrzymywania estru 2-[4-(4-fluoro-2-metylo-1H-indolo-5-iloksy)-5-metylopirolo[2,1-f][1,2,4]triazyn-6-iloksy]-1-metyloetylowego kwasu [(1R), 2S]-2-aminopropionowego PL2010538T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74530006P 2006-04-21 2006-04-21
EP07760872A EP2010538B1 (en) 2006-04-21 2007-04-19 PROCESS FOR THE PREPARATION OF Ý(1R), 2S¨-2-AMINOPROPIONIC ACID 2-Ý4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLOÝ2,1-f¨Ý1,2,4¨TRIAZIN-6-YLOXY¨-1-METHYLETHYL ESTER
PCT/US2007/066911 WO2007124332A1 (en) 2006-04-21 2007-04-19 PROCESS FOR THE PREPARATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTER

Publications (1)

Publication Number Publication Date
PL2010538T3 true PL2010538T3 (pl) 2013-04-30

Family

ID=38357966

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07760872T PL2010538T3 (pl) 2006-04-21 2007-04-19 Sposób otrzymywania estru 2-[4-(4-fluoro-2-metylo-1H-indolo-5-iloksy)-5-metylopirolo[2,1-f][1,2,4]triazyn-6-iloksy]-1-metyloetylowego kwasu [(1R), 2S]-2-aminopropionowego

Country Status (23)

Country Link
US (1) US7671199B2 (pl)
EP (1) EP2010538B1 (pl)
JP (1) JP5203353B2 (pl)
KR (1) KR101423789B1 (pl)
CN (1) CN101472927B (pl)
AR (1) AR060622A1 (pl)
AU (1) AU2007240453B2 (pl)
BR (1) BRPI0710691A2 (pl)
CA (1) CA2650059A1 (pl)
CL (2) CL2007001141A1 (pl)
DK (1) DK2010538T3 (pl)
EA (1) EA019693B1 (pl)
ES (1) ES2399379T3 (pl)
HR (1) HRP20130099T1 (pl)
IL (1) IL194715A (pl)
MX (1) MX2008013232A (pl)
NO (1) NO20084326L (pl)
PE (1) PE20080193A1 (pl)
PL (1) PL2010538T3 (pl)
PT (1) PT2010538E (pl)
SI (1) SI2010538T1 (pl)
TW (1) TWI378100B (pl)
WO (1) WO2007124332A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1928880A1 (en) * 2005-09-27 2008-06-11 Brystol-Myers Squibb Company Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
US20120135875A1 (en) * 2008-02-29 2012-05-31 Bristol-Myers Squibb Company Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
WO2010071885A1 (en) 2008-12-19 2010-06-24 Cephalon, Inc. Pyrrolotriazines as alk and jak2 inhibitors
EP3864418A1 (en) 2018-10-08 2021-08-18 Applied Photophysics Limited System and method for analysing the composition of a quenched flow reaction liquid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982265B1 (en) 1999-05-21 2006-01-03 Bristol Myers Squibb Company Pyrrolotriazine inhibitors of kinases
TWI329112B (en) * 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases
TWI272271B (en) 2002-07-19 2007-02-01 Bristol Myers Squibb Co Process for preparing certain pyrrolotriazine compounds
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7173031B2 (en) * 2004-06-28 2007-02-06 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
US7393667B2 (en) 2005-05-31 2008-07-01 Bristol-Myers Squibb Company Stereoselective reduction process for the preparation of pyrrolotriazine compounds
EP1928880A1 (en) 2005-09-27 2008-06-11 Brystol-Myers Squibb Company Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester

Also Published As

Publication number Publication date
EP2010538B1 (en) 2012-12-05
MX2008013232A (es) 2008-10-21
PT2010538E (pt) 2013-02-22
ES2399379T3 (es) 2013-04-01
HRP20130099T1 (hr) 2013-03-31
TW200808799A (en) 2008-02-16
NO20084326L (no) 2008-11-18
JP2009534413A (ja) 2009-09-24
CN101472927A (zh) 2009-07-01
JP5203353B2 (ja) 2013-06-05
CA2650059A1 (en) 2007-11-01
AR060622A1 (es) 2008-07-02
PE20080193A1 (es) 2008-03-10
KR20090008246A (ko) 2009-01-21
CL2010000554A1 (es) 2010-10-15
EA019693B1 (ru) 2014-05-30
BRPI0710691A2 (pt) 2011-08-23
KR101423789B1 (ko) 2014-07-30
CN101472927B (zh) 2012-07-04
AU2007240453B2 (en) 2012-04-12
EP2010538A1 (en) 2009-01-07
TWI378100B (en) 2012-12-01
SI2010538T1 (sl) 2013-06-28
WO2007124332A1 (en) 2007-11-01
EA200802171A1 (ru) 2009-08-28
DK2010538T3 (da) 2013-03-18
AU2007240453A1 (en) 2007-11-01
CL2007001141A1 (es) 2008-01-18
IL194715A (en) 2013-10-31
US20070249610A1 (en) 2007-10-25
US7671199B2 (en) 2010-03-02

Similar Documents

Publication Publication Date Title
ZA200709028B (en) Process for the production of acetic acid
DK3872059T3 (en) Process for the preparation of 2,3,3,3 tetrahydrofluoropropene
TWI371442B (en) Process for producing carboxylic acid
PL1993985T3 (pl) Sposób wytwarzania 1,2-propanodiolu
TWI449540B (en) Process for the production of an abuse-proofed dosage form
PL2137206T3 (pl) Sposób wytwarzania kwasu tauroursodeoksycholowego
IL183591A0 (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
HRP20181437T1 (hr) Postupak proizvodnje (3s,3s') 4,4' disulfanedilbis (3-aminobutan-1-sulfonske kiseline)
IL180311A0 (en) Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters
EP1950191A4 (en) PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONIC ACID
EP1939170A4 (en) PROCESS FOR PREPARING GABAPENTINE HYDROCHLORIDE
ZA200601910B (en) Process for the preparation of organosilances
EG25838A (en) Process for the preparation of amino acid methyl esters
EP2212325A4 (en) 2-ARYLMETHYLAZETIDINCARBAPENEM-3-CARBOXYLENE DERTERIVATE OR SALT, METHOD FOR THE PRODUCTION THEREOF AND THEREOF COMPRISING PHARMACEUTICAL COMPOSITION
PL2010538T3 (pl) Sposób otrzymywania estru 2-[4-(4-fluoro-2-metylo-1H-indolo-5-iloksy)-5-metylopirolo[2,1-f][1,2,4]triazyn-6-iloksy]-1-metyloetylowego kwasu [(1R), 2S]-2-aminopropionowego
EP2083003A4 (en) PROCESS FOR THE PREPARATION OF 1,1,1,3,3-PENTACHLOROBUTANE
GB0600712D0 (en) Process for the manufacture of substituted propionic acids
EP1996192A4 (en) PROCESS FOR PREPARING 3,4-SUBSTITUTED THIAZOLIDIN-2-ONES IN 3,4
EP2025663A4 (en) NOVEL CARBOXYLIC ACID COMPOUND, ITS APPLICATION AND METHOD OF PRODUCTION
EP2042589A4 (en) PROCESS FOR THE PREPARATION OF FATTY ACID ELECTRIC SYNTHESIS AND METHOD OF MANUFACTURING THE PROCESS
ZA200409433B (en) Process for the preparation of carboxylic acid esters.
EP2084168A4 (en) METHOD FOR PRODUCING HIGH-PURITY DIALKYL DITHIOPHOSPHIN COMPOUNDS
IL213171A (en) Composition for producing trans-2,2 dimethyl 3-formylcyclopropanecarboxylic acid ester
IL194330A0 (en) Processes for the synthesis of 3-isobutylglutaric acid